Teva Pharmaceutical Welcomes Matthew Shields as Executive Vice President of Global Operations

(Reference)

Jerusalem, Israel – June 3, 2024 – Teva Pharmaceutical Industries Ltd. has announced the appointment of Matthew Shields as the new Executive Vice President of Teva Global Operations (TGO), starting June 3, 2024. Shields will head the manufacturing and supply division, enhancing operational efficiencies across Teva’s worldwide network.

With an extensive background in managing global supply chains and manufacturing operations, Matthew Shields brings a wealth of experience to Teva. His previous roles have equipped him with the skills necessary to lead large-scale operations and implement strategic improvements effectively.

"Matthew is exceptionally qualified to direct Teva Global Operations. His understanding of complex production environments and his leadership skills are what Teva needs as we aim to meet the evolving demands of the healthcare market," said Kåre Schultz, President and CEO of Teva.

Matthew Shields commented on his new role, saying, "I am thrilled to join Teva, a company renowned for its commitment to making quality healthcare accessible. I look forward to applying my expertise to further strengthen our operational capabilities and ensure we continue to meet our commitments to patients globally."

Teva Pharmaceutical expects that Matthew Shields’ leadership will significantly contribute to the company's ongoing efforts to streamline operations and maintain its status as a key player in the global pharmaceutical market.

For more information about Teva’s operations and initiatives, visit Teva Pharmaceutical Industries’ website.